...BRCA1/2 mutation carriers by up to 95%, but the Italian attitude towards this procedure is reluctant.,This is an observa...
...BRCA1) and topoisomerase 1 (TOPO1), all in HT-29 and LoVo cells, with or without the addition of cinnamaldehyde, was exa...
...BRCA1 C-terminal (BRCT) domains are overrepresented in DNA damage and replication stress response proteins. They functio...
BRCA1, BRCA2, and PALB2 are key players in cellular tolerance to chemotherapeutic agents, including camptothecin, cispla...
To establish, if among unaffected noncarrier relatives in a family with an established BRCA1/2 mutation, there is an inc...
...BRCA1 and 6% (95% CI 2 to 11%) for BRCA2 mutation carriers. In BRCA1 families, breast cancer relative risk (RR) increase...
...BRCA1 or 2 have been validated as the first new predictive and prognostic biomarker of the high-grade serous ovarian can...
...BRCA1 or BRCA2. The significance of these genome-wide mutations is unknown. We hypothesize genome-wide mutation burden m...
...Brca1, and E-cadherin, were downregulated in K5.CtBP1 skin. Surprisingly, K5.CtBP1 pups also exhibited a hair loss pheno...
Strategies in case of high risk of breast cancer in BRCA1/2 mutation carriers are either intensive breast cancer screeni...
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com